Notice: This company has been marked as potentially delisted and may not be actively trading. Can B (CANB) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsEarningsHeadlinesTrends CANB vs. MEDS, BIMI, MCK, COR, CAH, HLF, NUS, COSM, HWH, and CRVOShould you be buying Can B stock or one of its competitors? The main competitors of Can B include TRxADE HEALTH (MEDS), BIMI (BIMI), McKesson (MCK), Cencora (COR), Cardinal Health (CAH), Herbalife (HLF), Nu Skin Enterprises (NUS), Cosmos Health (COSM), HWH International (HWH), and CervoMed (CRVO). Can B vs. TRxADE HEALTH BIMI McKesson Cencora Cardinal Health Herbalife Nu Skin Enterprises Cosmos Health HWH International CervoMed Can B (NASDAQ:CANB) and TRxADE HEALTH (NASDAQ:MEDS) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, valuation, media sentiment, risk, earnings, community ranking and profitability. Which has more risk and volatility, CANB or MEDS? Can B has a beta of 1.45, indicating that its stock price is 45% more volatile than the S&P 500. Comparatively, TRxADE HEALTH has a beta of 2.32, indicating that its stock price is 132% more volatile than the S&P 500. Is CANB or MEDS more profitable? TRxADE HEALTH has a net margin of -149.81% compared to Can B's net margin of -1,238.33%. Can B's return on equity of 0.00% beat TRxADE HEALTH's return on equity.Company Net Margins Return on Equity Return on Assets Can B-1,238.33% N/A -218.65% TRxADE HEALTH -149.81%-196.79%-112.21% Does the media prefer CANB or MEDS? In the previous week, TRxADE HEALTH's average media sentiment score of 0.00 beat Can B's score of -0.14 indicating that TRxADE HEALTH is being referred to more favorably in the news media. Company Overall Sentiment Can B Neutral TRxADE HEALTH Neutral Do institutionals and insiders have more ownership in CANB or MEDS? 6.1% of Can B shares are held by institutional investors. Comparatively, 5.7% of TRxADE HEALTH shares are held by institutional investors. 11.4% of Can B shares are held by company insiders. Comparatively, 48.4% of TRxADE HEALTH shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Does the MarketBeat Community prefer CANB or MEDS? TRxADE HEALTH received 4 more outperform votes than Can B when rated by MarketBeat users. However, 58.62% of users gave Can B an outperform vote while only 52.50% of users gave TRxADE HEALTH an outperform vote. CompanyUnderperformOutperformCan BOutperform Votes1758.62% Underperform Votes1241.38% TRxADE HEALTHOutperform Votes2152.50% Underperform Votes1947.50% Which has stronger earnings and valuation, CANB or MEDS? Can B has higher earnings, but lower revenue than TRxADE HEALTH. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCan B$2.16M1.45-$9.74MN/AN/ATRxADE HEALTH$7.45M0.70-$17.84MN/AN/A SummaryTRxADE HEALTH beats Can B on 7 of the 12 factors compared between the two stocks. Get Can B News Delivered to You Automatically Sign up to receive the latest news and ratings for CANB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CANB vs. The Competition Export to ExcelMetricCan BDrugs, proprietaries, & sundries IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.46M$19.37B$5.62B$9.14BDividend YieldN/A1.45%5.36%3.98%P/E RatioN/A10.5189.6917.66Price / Sales1.451.241,219.4081.09Price / CashN/A12.3044.3437.71Price / Book-0.1415.875.134.73Net Income-$9.74M$776.36M$118.85M$225.42M Can B Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CANBCan BN/A$0.04+11.1%N/A+33.3%$4.46M$2.16M0.0016High Trading VolumeMEDSTRxADE HEALTHN/A$4.36+3.9%N/A-15.8%$6.13M$7.45M0.0050Gap DownBIMIBIMIN/A$0.00flatN/A-100.0%$1,000.00$11.83M0.00520News CoveragePositive NewsMCKMcKesson4.7987 of 5 stars$603.75+2.1%$646.14+7.0%+24.1%$76.24B$308.95B31.1051,000Upcoming EarningsDividend AnnouncementNews CoveragePositive NewsCORCencora4.6268 of 5 stars$254.68+2.5%$277.00+8.8%+17.4%$49.09B$293.96B33.8246,000Upcoming EarningsAnalyst ForecastShort Interest ↓News CoveragePositive NewsCAHCardinal Health4.7752 of 5 stars$130.65+1.4%$134.64+3.1%+20.0%$31.47B$226.83B25.2948,900Earnings ReportAnalyst ForecastNews CoveragePositive NewsHLFHerbalife4.6475 of 5 stars$6.52+1.0%$9.90+52.0%-53.7%$657.67M$5.00B7.689,200Short Interest ↑News CoverageNUSNu Skin Enterprises3.0195 of 5 stars$7.01+1.7%$6.88-1.9%-63.5%$350.71M$1.78B-3.413,700Short Interest ↑COSMCosmos Health1.5268 of 5 stars$0.79+0.2%N/A-36.3%$18.26M$53.38M-0.32100Gap DownHWHHWH InternationalN/A$0.50+72.4%N/A-72.8%$15.44MN/A0.00N/AShort Interest ↓Gap DownHigh Trading VolumeCRVOCervoMed3.555 of 5 stars$2.24-3.0%$42.00+1,775.0%-73.9%$13.82M$7.14M0.004Short Interest ↓News Coverage Related Companies and Tools Related Companies MEDS Competitors BIMI Competitors MCK Competitors COR Competitors CAH Competitors HLF Competitors NUS Competitors COSM Competitors HWH Competitors CRVO Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CANB) was last updated on 1/30/2025 by MarketBeat.com Staff From Our PartnersIs Big Tech dead?China just threw a “$5.5 million” curveball called Deep Seek to Silicon Valley and the timing of it is no coin...Brownstone Research | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredTrump’s back in the oval office. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. And he says 2025 could be...Weiss Ratings | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredMust-See: 5-Second Trump PredictionPresident Trump's prediction is about to become a reality... Opening a rare window of opportunity for you t...InvestorPlace | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Can B Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Can B With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
